Akèy › Lukemi miyomonositè kwonik › Alabama › Birmingham
Etid klinik pou Lukemi miyomonositè kwonik nan Birmingham, AL
4 etid pou Lukemi miyomonositè kwonik ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 2
- The University of Alabama at Birmingham, Birmingham
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Ap rekriteEtid obsèvasyon
- AllerVie Clinical Research, Birmingham
- O'Neal Comprehensive Cancer Center at the UAB, Birmingham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 2
- University of Alabama Birmingham, Birmingham
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1/2
- The Kirklin Clinic of UAB Hospital, Birmingham
Etid Lukemi miyomonositè kwonik nan lòt vil
- Houston, TX16 etid
- Seattle, WA10 etid
- Boston, MA7 etid
- Mountain View, CA6 etid
- Baldwin Park, CA6 etid
- Rochester, MN6 etid
- New York City, NY6 etid
- Durham, NC5 etid
- Miami, FL4 etid
- Tampa, FL4 etid
- Columbus, OH4 etid
- Atlanta, GA4 etid
Lòt etid nan Birmingham
- Kansè (tout kalite)31 etid
- Kansè nan tete24 etid
- Kansè ovè23 etid
- Obèsite23 etid
- Kansè Poumon ki pa ti selil22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip18 etid
- BPCO17 etid
- Maladi kadyovaskilè17 etid
- Dyabèt Tip 216 etid
- Kansè Endomèt16 etid
- Sipwa16 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.